Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
Rioghna R PittockJeremiah AakreAnna M CastilloVijay K RamananWalter K KremersClifford R JackPrashanthi VemuriVal J LoweDavid S KnopmanRonald C PetersenJonathan Graff-RadfordMaria VassilakiPublished in: Neurology (2023)
Findings estimate the limited eligibility in typical older adults with cognitive impairment for anti-beta amyloid mAbs.